Observational studyMedicine2025
Management of severe diabetic foot using modified transverse bone transport: A retrospective study of Wagner grade 3 to 4 cases.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates the effectiveness of a modified transverse tibial bone transport technique (combining bone and periosteum transfer) in treating Wagner grade 3 to 4 diabetic foot. This retrospective study included patients diagnosed with Wagner grade 3 to 4 diabetic foot, with a minimum follow-up duration of 6 months. Key selection criteria included adequate lower limb vascularity confirmed by CT angiography (CTA) and no major systemic contraindications. The study assessed foot and limb preservation rates, ulcer healing time, complications, foot skin temperature, resting pain (visual analog scale (VAS) score), and CTA changes before and after surgery. The mean follow-up was 11.43 ± 3.75 months. Significant improvements were observed in key outcomes: foot temperature increased from 33.43 ± 0.87°C preoperatively to 36.02 ± 0.88°C at 8 weeks post-op (P < .001), and VAS pain scores decreased from 4.87 ± 1.02 preoperatively to 2.87 ± 0.77 at 8 weeks post-op (P < .001). Ulcers healed in 93.75% of cases, with a mean healing time of 8.46 ± 1.79 weeks. The overall complication rate was 10.42%, and 79.17% of patients showed improved vascularization. Modified transverse tibial bone transport may support microvascular regeneration, improve foot temperature, alleviate pain, and promote ulcer healing, demonstrating favorable clinical outcomes and a low incidence of complications in patients with severe diabetic foot. Given the retrospective nature of this study and the absence of a control group, further research with prospective controlled designs is necessary to confirm these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.